1-butoxyethyl acetate | 33931-54-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-butoxyethyl acetate
• 英文别名: butoxyethanol acetate
• CAS: 33931-54-3
• 化学式: C₈H₁₆O₃
• 分子量: 160.213
• InChiKey: HICGBKHFZLOTKR-UHFFFAOYSA-N

物化性质

• 沸点：
  166-172 °C
• 密度：
  0.9193 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2915390090

反应信息

• 作为反应物：
  描述：

  溴丁基-镁 、 1-butoxyethyl acetate 在 乙醚 作用下， 生成 丁基-(1-甲基-戊基)-醚
  参考文献：
  名称：

  Schostakowskii; Kulibekow, Zhurnal Obshchei Khimii, 1958, vol. 28, p. 2339; engl. Ausg. S. 2376

  摘要：

  DOI：
• 作为产物：
  描述：

  乙烯基正丁醚 在 盐酸 作用下， 生成 1-butoxyethyl acetate
  参考文献：
  名称：

  Schosstakowski; Bogdanowa, Zhurnal Obshchei Khimii, 1947, vol. 17, p. 573

  摘要：

  DOI：

文献信息

• FUNCTIONALIZED COPOLYMERS AND USE THEREOF
  申请人：3M INNOVATIVE PROPERTIES COMPANY

  公开号：US20210031152A1

  公开（公告）日：2021-02-04

  An article that includes a functionalized copolymer and the use thereof, particularly in a process for binding biomaterials, such as in a process for separating aggregated proteins from monomeric proteins in a biological solution; wherein the article includes: a) a porous substrate; and b) a copolymer covalently attached to the porous substrate, the copolymer comprising a hydrocarbon backbone and a plurality of pendant groups attached to the hydrocarbon backbone, wherein 1) each of a first plurality of pendant groups comprises: (a) at least one acidic group or salt thereof; and (b) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and 2) each of a second plurality of pendant groups comprises: (a) at least one acidic group or salt thereof; and (b) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and wherein the first plurality of pendant groups are different than the second plurality of pendant groups; and wherein a mole ratio of the first plurality of pendant groups to the second plurality of pendant groups is in a range of 95:5 to 5:95.

  一篇包括功能化共聚物及其用途的文章，特别是在结合生物材料的过程中使用，例如在从生物溶液中分离聚集蛋白质和单体蛋白质的过程中；其中该文章包括：a) 多孔基底；和 b) 共价连接到多孔基底上的共聚物，该共聚物包括一个碳氢骨架和多个连接到碳氢骨架上的挂链基团，其中1) 第一多数挂链基团中的每一个包括：(a) 至少一个酸性基团或其盐；和 (b) 一个通过至少6个串联原子链直接将至少一个酸性基团或其盐连接到碳氢骨架的空间基团；和 2) 第二多数挂链基团中的每一个包括：(a) 至少一个酸性基团或其盐；和 (b) 一个通过至少6个串联原子链直接将至少一个酸性基团或其盐连接到碳氢骨架的空间基团；其中第一多数挂链基团不同于第二多数挂链基团；并且第一多数挂链基团与第二多数挂链基团的摩尔比在95:5到5:95的范围内。
• [EN] PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION<br/>[FR] PROCÉDÉS DE SÉPARATION DE PROTÉINES AGRÉGÉES À PARTIR DE PROTÉINES MONOMÈRES DANS UNE SOLUTION BIOLOGIQUE
  申请人：3M INNOVATIVE PROPERTIES CO

  公开号：WO2018048698A1

  公开（公告）日：2018-03-15

  A process for separating aggregated proteins from monomeric proteins in a biological solution, the process including: providing at least one filter element having a contacting surface, wherein the filter element comprises filter media comprising: a porous substrate; and disposed on the porous substrate, a polymer comprising a hydrocarbon backbone and a plurality of pendant groups attached to the hydrocarbon backbone, wherein each of a first plurality of pendant groups comprises: (1) at least one acidic group or salt thereof; and (2) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and allowing an initial biological solution to contact the contacting surface of the filter element under conditions effective to separate the aggregated proteins from the monomeric proteins such that a final biological solution includes purified monomeric proteins.

  一种从生物溶液中分离聚集蛋白质和单体蛋白质的方法，该方法包括：提供至少一个具有接触表面的过滤元件，其中过滤元件包括包括过滤介质的多孔基质；并且在多孔基质上设置了一种聚合物，该聚合物包括一个烃骨架和附着在烃骨架上的多个偏基团，其中第一多个偏基团中的每一个包括：（1）至少一个酸性基团或其盐；和（2）一个间隔基团，通过至少6个串联原子的链将至少一个酸性基团或其盐直接连接到烃骨架；并且允许初始生物溶液在有效条件下接触过滤元件的接触表面，以使聚集蛋白质与单体蛋白质分离，从而得到含有纯化单体蛋白质的最终生物溶液。
• [EN] 2- (TERT - BUTOXY) -2- (7 -METHYLQUINOLIN- 6 - YL) ACETIC ACID DERIVATIVES FOR TREATING AIDS<br/>[FR] DÉRIVÉS D'ACIDE 2-(TERT-BUTOXY)-2-(7-MÉTHYLQUINOLÉIN-6-YL)ACÉTIQUE POUR TRAITER LE SIDA
  申请人：GILEAD SCIENCES INC

  公开号：WO2013103724A1

  公开（公告）日：2013-07-11

  The invention provides compounds and salts thereof as d herein. The invention also provides pharmaceutical compositions comprising a compound disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection, treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds disclosed herein.

  本发明提供作为d的化合物及其盐。本发明还提供包括本文所披露的化合物的药物组合物，用于制备本文所披露的化合物的方法，用于制备本文所披露的化合物的有用中间体，以及使用本文所披露的化合物治疗HIV感染、治疗HIV病毒的增殖、治疗艾滋病或延缓哺乳动物发生艾滋病或ARC症状的治疗方法。
• [EN] PROCESS FOR OBTAINING (S)-2-BENZYL-4-((3AR,7AS)-HEXAHYDRO-1 H-ISOINDOL- 2(3H)-YL)-4-OXOBUTANOIC ACID AND SALTS THEREOF<br/>[FR] PROCÉDÉ POUR L'OBTENTION D'ACIDE (S)-2-BENZYL-4-((3AR,7AS)-HEXAHYDRO-1H-ISOINDOL-2(3H)-YL)-4-OXOBUTANOÏQUE ET DE SELS DE CELUI-CI
  申请人：LESVI LABORATORIOS SL

  公开号：WO2013189829A1

  公开（公告）日：2013-12-27

  Comprising reacting compound (IV) with compound (V) in a solvent to give (S)-mitiglinide (II) and compound (III) as a by- product; removing the solvent and adding ethyl acetate to precipitate compound (III); collecting the solid and applying at least one cycle process comprising: - refluxing the solution of compound (III) with an organic solvent to give (S)-mitiglinide (II) and further compound (III) as a by-product, - removing the organic solvent and adding ethyl acetate to precipitate compound (III); and - separating the mother liquors from the solid, and mixing all the mother liquors; removing the ethyl acetate from the mother liquors to obtain (S)-mitiglinide.

  将化合物（IV）与化合物（V）在溶剂中反应，得到（S）-米格林肽（II）和化合物（III）作为副产物；去除溶剂并加入乙酸乙酯以沉淀化合物（III）；收集固体并应用至少一个循环过程，包括：- 用有机溶剂回流化合物（III）的溶液，得到（S）-米格林肽（II）和进一步的化合物（III）作为副产物，- 去除有机溶剂并加入乙酸乙酯以沉淀化合物（III）；- 将母液与固体分离，并混合所有母液；从母液中去除乙酸乙酯以获得（S）-米格林肽。
• PREPARATION OF DIHYDROPYRIDINES
  申请人：VISHNU NEWADKAR RAVINDRANATH

  公开号：US20110275825A1

  公开（公告）日：2011-11-10

  The invention relates to a method and compounds for the preparation of clevidipine butyrate, a very short acting hypertensive calcium antagonist, as well as the synthesis of these compounds useful for the preparation of clevidipine (also known as clevidipine butyrate). Moreover the invention also discloses polymorphic forms of clevidipine butyrate, useful for the preparation of pharmaceutical compositions, and processes to prepare them.

  该发明涉及一种用于制备克莱维地平丁酸酯的方法和化合物，克莱维地平丁酸酯是一种作用时间非常短的高血压钙拮抗剂，以及用于制备克莱维地平（也称为克莱维地平丁酸酯）的这些化合物的合成。此外，该发明还揭示了克莱维地平丁酸酯的多态形式，用于制备药物组合物，并揭示了用于制备这些多态形式的方法。